Unknown

Dataset Information

0

Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis.


ABSTRACT: Ethionamide (ETH) is a second-line drug for the treatment of tuberculosis. As a prodrug, ETH has to be activated by EthA. ethA is controlled by its repressor EthR. 2-Phenylethyl-butyrate (2-PEB) inhibits EthR binding, enhances expression of EthA, and thereby enhances the growth-inhibitory effects of ethionamide, isoxyl, and thiacetazone in Mycobacterium tuberculosis strains with resistance to ETH due to inhA promoter mutations but not ethA mutations.

SUBMITTER: Grau T 

PROVIDER: S-EPMC3264283 | biostudies-literature | 2012 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis.

Grau Thomas T   Selchow Petra P   Tigges Marcel M   Burri Reto R   Gitzinger Marc M   Böttger Erik C EC   Fussenegger Martin M   Sander Peter P  

Antimicrobial agents and chemotherapy 20111121 2


Ethionamide (ETH) is a second-line drug for the treatment of tuberculosis. As a prodrug, ETH has to be activated by EthA. ethA is controlled by its repressor EthR. 2-Phenylethyl-butyrate (2-PEB) inhibits EthR binding, enhances expression of EthA, and thereby enhances the growth-inhibitory effects of ethionamide, isoxyl, and thiacetazone in Mycobacterium tuberculosis strains with resistance to ETH due to inhA promoter mutations but not ethA mutations. ...[more]

Similar Datasets

| S-EPMC5278698 | biostudies-literature
| S-EPMC5536135 | biostudies-other
| S-EPMC5442550 | biostudies-literature
| S-EPMC6963291 | biostudies-literature
| S-EPMC3910714 | biostudies-literature
| S-EPMC3372151 | biostudies-literature
| S-EPMC10376136 | biostudies-literature
| S-EPMC2863904 | biostudies-literature
| S-EPMC10434885 | biostudies-literature
| S-EPMC5571295 | biostudies-literature